27871-89-2

Basic information

• Product Name: 2-Cyclohexene-1-carboxylic acid, 2-hydroxy-4-oxo-6-pentyl-, methyl ester
• Synonyms: methyl 2-hydroxy-4-oxo-6-pentyl-2-cyclohexene-1-carboxylate;CYC075;2-Cyclohexene-1-carboxylic acid,2-hydroxy-4-oxo-6-pentyl-,methyl ester
• CAS NO: 27871-89-2
• Molecular Formula: C13H20O4
• Molecular Weight: 240.299
• Mol File: 27871-89-2.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 349.2±42.0 °C(Predicted)
• Density: 1.112±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 2-Cyclohexene-1-carboxylic acid, 2-hydroxy-4-oxo-6-pentyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Cyclohexene-1-carboxylic acid, 2-hydroxy-4-oxo-6-pentyl-, methyl ester(27871-89-2)
• EPA Substance Registry System: 2-Cyclohexene-1-carboxylic acid, 2-hydroxy-4-oxo-6-pentyl-, methyl ester(27871-89-2)

Safety Data

• Hazardous Substances Data: 27871-89-2(Hazardous Substances Data)

Usage

General Description

2-Cyclohexene-1-carboxylic acid, 2-hydroxy-4-oxo-6-pentyl-, methyl ester is a chemical compound with a complex structure. The presence of cyclohexene and carboxylic acid groups indicates its potential use in organic synthesis and chemical reactions. The 2-hydroxy-4-oxo-6-pentyl moiety suggests its role as a potential precursor in the synthesis of other compounds, or as a building block for more complex molecules. The methyl ester functional group makes it suitable for use as an ester in various chemical reactions. Overall, this chemical compound has potential uses in fields such as organic chemistry, pharmaceuticals, and chemical manufacturing.

Upstream product

• 14309-57-0 Non-3-en-2-on 
• 108-59-8 malonic acid dimethyl ester 

Downstream Products

• 500-66-3 Olivetol 

Relevant articles and documents

BIOENZYMATIC SYNTHESIS OF THC-v, CBV AND CBN AND THEIR USE AS THERAPEUTIC AGENTS

The present invention provides methods for producing cannabinoids. More specifically, the invention is directed to the bio-enzymatic synthesis of THC-v, CBV and CBN by contacting a compound according to Formula I with a cannabinoid synthase enzyme. Also described is a system for producing these pharmaceutically important cannabinoids and the use of such cannabinoids as therapeutic agents.

METHODS FOR THE MANUFACTURE OF CANNABINOID PRODRUGS, PHARMACEUTICAL FORMULATIONS AND THEIR USE

Described are methods for producing cannabinoid prodrugs as well as methods for formulating such prodrugs in a pharmaceutically acceptable form and their use as therapeutic agents for treating diseases.

BIOSYNTHESIS OF CANNABINOIDS

The present invention provides methods for producing cannabinoids and cannabinoid analogs as well as a system for producing these compounds. The inventive method is directed to contacting a compound according to Formula I or Formula II with a cannabinoid synthase. Also described is a system for producing cannabinoids and cannabinoid analogs by contacting a THCA synthase with a cannabinoid precursor and modifying at least one property of the reaction mixture to influence the quantity formed of a first cannabinoid relative to the quantity formed of a second cannabinoid.